ConductScience.org, home

Library / Genes

NELFCD: negative elongation factor complex member C/D

1 protein, 23 patents, 0 drugs, 0 trials, 3,569 NIH grants and 5,139 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolNELFCDHGNC
Namenegative elongation factor complex member C/DHGNC
NCBI Gene ID51497NCBI Gene
HGNC IDHGNC:15934HGNC
EnsemblENSG00000101158NCBI Gene
AliasesHSPC130, NELF-C, NELF-D, TH1, TH1LNCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
Q8IXH7Negative elongation factor C/D59016Ensembl, GeneID, HGNCUniProt

Patents 23

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1466917Q8IXH7Espacenet
JP 2026004568 A2026-01-1466918Q8IXH7Espacenet
EP 4650780 A22025-11-1939668Q8IXH7Espacenet
JP 2025517970 A2025-06-1239668Q8IXH7Espacenet
WO 2020043864 A12020-03-051627Q8IXH7Espacenet
JP 2019054813 A2019-04-11247352Q8IXH7Espacenet
JP 2019054813 A2019-04-11247353Q8IXH7Espacenet
EP 3407066 A12018-11-2885Q8IXH7Espacenet
US 10041947 B22018-08-0785Q8IXH7Espacenet
US 9880168 B22018-01-3085Q8IXH7Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 3569

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA016672Cancer Center Support Grant242,025NIH's project files
P30CA008748Cancer Center Support Grant212,025NIH's project files
UL1TR001866Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success182,025NIH's project files
U19AI057266Vaccine and Infection Induced Immunity in the Young and Aged152,025NIH's project files
R01HL117913The NOTCH Signaling Pathway in Large Vessel Vasculitis92,025NIH's project files
P30CA006973Regional Oncology Research Center82,025NIH's project files
P30DK058404Molecular and Cellular Basis for Digestive Diseases82,025NIH's project files
P30ES010126UNC Center for Environmental Health and Susceptibility82,025NIH's project files
P30CA014520UW Comprehensive Cancer Center Support72,025NIH's project files
UL1TR001863Yale Clinical and Translational Science Award72,025NIH's project files

Papers 5139

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42818875PubTator, text miningPubMed
42786145PubTator, text miningPubMed
42695969PubTator, text miningPubMed
42592192PubTator, text miningPubMed
42581788PubTator, text miningPubMed
42539146PubTator, text miningPubMed
42456643PubTator, text miningPubMed
41892077PubTator, text miningPubMed
41860999PubTator, text miningPubMed
41824183PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license